DeFloria announced Thursday that its experimental cannabis-based drug for autism spectrum disorder showed positive early results, with patients tolerating the treatment well across multiple dose levels. The drug, AJA001, being developed as a multi-compound hemp extract with a full spectrum of cannabinoids, demonstrated safety at daily doses up to 660 …

This story was republished with permission from Crain’s Cleveland. Statewide cannabis sales have held relatively steady at elevated levels in the four months since the launch of Ohio’s adult-use market, according to the latest figures from the Ohio Division of Cannabis Control. Ohio dispensaries sold a little shy of $74… …